Collagen
Collagen is the most abundant protein in the human body, providing the structural scaffold for skin, joints, bones, and tendons. Supplemental collagen (mostly hydrolysed bovine or marine peptides) is digested into individual amino acids and short peptides. There is no UK-authorised health claim for collagen supplementation despite the marketing. This entry leads with UK and EU authoritative guidance — the NHS, NICE, EFSA, the GB Nutrition and Health Claims register, and the relevant specialist societies (Versus Arthritis, the Royal Osteoporosis Society) — as the primary reference layer; Camden's own appraisal of the primary trial literature sits beneath that guidance as a secondary layer.
Camden Medicals editorial · Last reviewed 27 April 2026 · Next review October 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Protein
- Typical daily dose
- Hydrolysed collagen peptides 2.5-10 g/day for 8-12+ weeks for skin endpoints; 10 g/day for joint endpoints; undenatured Type II collagen (UC-II) 10-40 mg/day for joint endpoints (a different preparation entirely). Collagen is not an essential nutrient — the body synthesises it from amino acids — so there is no UK reference intake.
- Top use evidence
- Limited
On this page
What it is
Collagen is a family of structural proteins built around a triple-helix of three polypeptide chains, rich in the amino acids glycine, proline, and hydroxyproline. Type I collagen dominates skin, bone, and tendon; Type II is the cartilage collagen; Type III appears in skin and blood vessels.
Four animal sources dominate UK supplements. Bovine collagen (cattle hide, bone, and tendon) is the most common and the cheapest. Marine collagen (fish skin and scales) is popular as a halal-friendly option and tends to be lower in molecular weight. Porcine collagen (pig skin) is widely produced but is neither halal nor kosher. Chicken collagen (chicken cartilage) is Type II and is marketed specifically for joint support.
Four forms are sold. Hydrolysed collagen peptides (typically 2-5 kDa, water-soluble, partially absorbed as small peptides and amino acids) are what most clinical trials have used. Intact native collagen is not absorbed as collagen by the digestive tract. Denatured collagen is gelatin (see /supplements/gelatin/). Undenatured Type II collagen (UC-II, ~10-40 mg/day) is a low-dose immunomodulatory preparation studied for knee osteoarthritis.
At a glance
- Hydrolysed peptides are absorbed; intact collagen is broken down to amino acids during digestion and is not absorbed as collagen.
- Trial evidence for skin and joint endpoints exists but study quality varies, effect sizes are modest, and many trials are industry-funded.
- Marine vs bovine vs porcine — sourcing matters more for halal / kosher / sustainability than for efficacy; head-to-head data is sparse.
- No GB NHC authorised health claim for collagen. Where a collagen product carries a skin / bone / cartilage claim on the label, that claim belongs to the vitamin C in the formulation, not the collagen.
- Talk to your GP if joint pain is new or persistent — there are diagnosable causes (osteoarthritis, inflammatory arthritis, injury) that a supplement will not address.
What people use it for
Adults with joint discomfort or early-stage knee osteoarthritis
Evidence is limited. UC-II (undenatured Type II collagen, 40 mg/day) has shown a small but statistically significant improvement in WOMAC scores at 180 days in one multicentre RCT. Hydrolysed collagen at 10 g/day has shown modest signals in some trials. NICE NG226 (osteoarthritis in over-16s) does not recommend collagen supplements as a treatment. Talk to your GP if joint pain is new, severe, or persistent — diagnosis guides management. [8,2]
Some evidenceLimitedAdults with skin-ageing concerns (wrinkles, hydration, elasticity)
A 2019 systematic review (Choi et al., 11 RCTs, 805 participants) and a 2021 meta-analysis (de Miranda et al., 19 RCTs, 1,125 participants) both report modest improvements in skin elasticity and hydration with hydrolysed collagen at 2.5-10 g/day for 8-12+ weeks. Effect sizes are modest, outcome measures (Cutometer, corneometer) are surrogate rather than patient-reported, and many trials are industry-funded. Collagen is not a substitute for sun protection. [6,7]
Some evidenceLimitedAthletes recovering from tendon injury
Emerging signal. A 2019 RCT (Praet et al.) in Achilles tendinopathy found that hydrolysed collagen peptides combined with a structured calf-strengthening programme produced larger VISA-A score improvements at three months than exercise plus placebo. Single trial; replication is limited. The exercise programme is the load-bearing intervention. [10]
Some evidenceLimitedHalal, kosher, or fish-allergic shoppers
Sourcing is the key question. Marine collagen avoids beef and pork but is a fish allergen. Bovine collagen is kosher only with kosher slaughter and a recognised certification (OU, KLBD); halal only with HFA / JAKIM certification. Porcine collagen is neither. Most UK supplement labels declare the species; a label that says only "collagen" without a species is a quality red flag.
Popular, not provenInsufficientVegans and vegetarians
Vegan collagen does not exist as actual collagen. Products marketed as "vegan collagen builders" are amino-acid stacks (typically glycine, proline, lysine) plus vitamin C, with the legal claim carried by vitamin C contributing to normal collagen formation. Whether oral amino-acid supplementation meaningfully changes endogenous collagen synthesis in well-fed adults is not established.
Popular, not provenInsufficient
How it works
Hydrolysed collagen peptides are digested to individual amino acids and short di- and tri-peptides; some intact peptides (notably hydroxyproline-containing dipeptides) reach circulation in nanomolar concentrations. The proposed mechanism for the modest skin and joint effects seen in some trials is a low-level signalling effect on fibroblasts and chondrocytes via these peptides, although the human evidence base is inconsistent and the systemic mechanism remains debated.
Common myths
Myth"Collagen capsules and drinks rebuild the collagen in your face"
RealityOnce oral collagen is digested, the resulting amino acids and short peptides distribute throughout the body via the bloodstream. There is no targeting mechanism that redirects them specifically to facial dermal collagen. The modest improvements in skin elasticity and hydration measured in some trials reflect a low-level systemic signal, not a delivery truck for collagen replacement. Marketing that frames it as targeted skin rebuild is not how nutrient absorption works. [6,7]
Myth"Marine collagen is dramatically better than bovine"
RealityHead-to-head clinical data is sparse and does not establish a clear winner on patient-meaningful endpoints. Marine collagen tends to a lower molecular weight; this has been used as a marketing point, but the link between molecular weight and clinical outcome is not established at the doses sold. For most consumers, sourcing matters more for halal / kosher / sustainability / fish allergy than for efficacy.
Myth"Vegan collagen exists"
RealityNo. Collagen is an animal protein. \"Vegan collagen\" products are amino-acid plus vitamin C formulations marketed using the word collagen. The GB-authorised health claim that legally travels with them belongs to vitamin C (contributing to normal collagen formation), not to the amino-acid stack itself. The labelling is borderline-misleading and ASA has historically challenged similar phrasings. [1]
Myth"More collagen equals more youthful skin"
RealityThe dose-response evidence for collagen is weak. Effective trial doses sit between 2.5 and 10 g/day for skin endpoints, but the evidence ceiling is modest — beyond 10 g/day there is no good evidence of additional benefit, and high-dose protein intake from any source carries its own considerations (kidney function, levothyroxine absorption timing, calorie load). [7]
Myth"Gelatin in a capsule shell delivers a useful collagen dose"
RealityA two-piece capsule shell weighs around 75-100 mg, of which gelatin (partially hydrolysed collagen) is most of the mass. That is two orders of magnitude below the trial-relevant hydrolysed collagen dose of several grams per day. The capsule shell is not a meaningful collagen source. See /supplements/gelatin/.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Collagen. Each answer is editorial and links to its evidence in the Sources list below.
Is hydrolysed collagen actually absorbed?
Partially. Hydrolysed collagen peptides (typically 2-5 kDa) are broken down further during digestion to individual amino acids (glycine, proline, hydroxyproline are abundant) and short di- and tri-peptides. Some intact hydroxyproline-containing dipeptides (such as Pro-Hyp) have been measured in human plasma after oral hydrolysed collagen. Intact native collagen, by contrast, is broken down completely during digestion and does not reach circulation as collagen. Whether the small amounts of circulating peptides translate into a meaningful biological effect on skin or joints is the unresolved question — the clinical evidence is modest at best. [6]
Marine vs bovine collagen — which is better?
For efficacy, head-to-head data is sparse and no clear winner emerges. Marine collagen tends to have a lower molecular weight and may absorb slightly faster in some pharmacokinetic studies, but the two have not been shown to differ meaningfully on clinical endpoints in adequately-powered trials. The decision is usually about diet (marine for halal-friendly options, but a fish allergen; bovine for non-pork preference; porcine for cost), sustainability (marine sourcing varies widely in sustainability), and price. The bigger quality question is whether the product is hydrolysed at all and whether the species and tissue are declared.
Does vegan collagen exist?
No, not as actual collagen. Collagen is an animal protein. UK products marketed as \"vegan collagen\" or \"plant-based collagen\" are amino-acid stacks (commonly glycine, proline, and lysine) combined with vitamin C, and sometimes silica or biotin. The GB NHC authorised health claim that travels with these products is the vitamin C claim — \"vitamin C contributes to normal collagen formation for the normal function of skin / bones / cartilage\" — which is a vitamin C claim, not a vegan collagen claim. If you are vegan, you are buying vitamin C with amino-acid garnish; that may or may not be useful, but it is not collagen. [1]
What dose for skin? What dose for joints?
Trial doses for skin endpoints have ranged from 2.5 to 10 g/day of hydrolysed collagen peptides for 8-12+ weeks (Choi 2019 review; de Miranda 2021 meta-analysis). Trial doses for joint endpoints are split: undenatured Type II collagen (UC-II) is a low-dose preparation at 10-40 mg/day; hydrolysed collagen at 10 g/day is the more common joint-trial dose. There is no UK authorised dose-response and \"more\" is not better-supported at the evidence ceiling. [6,8,7]
Can collagen replace dietary protein?
No. Collagen is a low-quality protein by amino-acid score: it is essentially devoid of tryptophan and is low in several other essential amino acids. As a protein source for muscle synthesis or general dietary adequacy it is inferior to whey, soy, egg, and most whole-food proteins. Use it as a targeted supplement if you choose to, not as a daily protein source.
Morning or evening — does timing matter?
No clear evidence that timing matters for collagen peptides. Trials have used a range of dosing schedules (with breakfast, before bed, split doses) and have not directly compared timings on clinical endpoints. Take it when you will remember to take it consistently — adherence over months matters more than time of day.
Is the biotin in a collagen gummy useful?
At the doses typically found in collagen-plus-vitamin gummies (50-100 µg of biotin, around 100% of the UK NRV), biotin contributes to the GB-authorised \"maintenance of normal hair and skin\" claim and is not a problem for blood-test immunoassays. The lab-test interference issue arises only at high-dose biotin (5,000-10,000 µg), which is not what a collagen gummy contains. See /supplements/biotin/ if you also take a separate high-strength biotin product.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Skin elasticity and hydration in healthy adults
LimitedEvidencelimitedUK/EU authoritative guidance first: EFSA assessed a skin-related collagen-peptide health-claim application and did not accept it, and the GB Nutrition and Health Claims register carries no authorised collagen claim for skin — the authorised skin claim that appears on collagen products is the vitamin C "contributes to normal collagen formation" claim, not a collagen claim. Camden's own reading of the primary trial literature beneath that guidance: the Choi 2019 systematic review (J Drugs Dermatol, 11 RCTs, 805 participants) and the de Miranda 2021 meta-analysis (Int J Dermatol, 19 RCTs, 1,125 participants) both report measurable improvements in skin elasticity and hydration with hydrolysed collagen peptides at 2.5-10 g/day for 8-12+ weeks. Effect sizes are modest, outcome measures are largely surrogate (Cutometer-derived elasticity, corneometer-derived hydration) rather than patient-reported, and a substantial fraction of included trials were industry-funded. The signal is real enough to be reproducible across reviews but not strong enough to support marketing collagen as an anti-wrinkle or skin-rejuvenation supplement under UK rules. [6,7]
Knee osteoarthritis — undenatured Type II collagen (UC-II)
LimitedEvidencelimitedUK/EU authoritative guidance first: NICE NG226 does not include collagen among recommended osteoarthritis treatments, the NHS osteoarthritis page does not list it, and EFSA did not establish a cause-and-effect relationship between collagen hydrolysate and joint maintenance. Versus Arthritis describes the joint evidence as mixed, with undenatured type II collagen offering at most a small symptom benefit over several months. Camden's own reading of the primary trial literature beneath that guidance: The Lugo 2016 multicentre RCT (Nutr J, N=191, 180 days) compared UC-II 40 mg/day to placebo and to glucosamine-chondroitin in adults with knee osteoarthritis. The UC-II arm showed a small but statistically significant improvement in WOMAC pain, stiffness, and physical-function scores compared with placebo. The trial is single-sponsor and the magnitude of benefit is modest. NICE NG226 (osteoarthritis in over-16s, 2022 update) does not recommend collagen supplements as part of standard osteoarthritis management. [8,2]
Knee osteoarthritis — hydrolysed collagen
InsufficientEvidenceinsufficientUK/EU authoritative guidance first: NICE NG226 does not endorse hydrolysed collagen for osteoarthritis and the NHS directs people to exercise, weight management and clinician-guided analgesia; EFSA did not substantiate a joint claim. Camden's own reading beneath that guidance: Trials of hydrolysed collagen at 10 g/day for knee osteoarthritis symptoms exist but are heterogeneous in design, duration, and outcome measures. No NICE-endorsed evidence base supports hydrolysed collagen as a treatment for osteoarthritis. The condition has effective UK pathways (weight management, structured exercise, topical and oral analgesia per NICE NG226). [2]
Achilles tendinopathy
LimitedEvidencelimitedUK/EU authoritative guidance first: no NICE guideline, NHS page or GB authorised health claim supports collagen for tendinopathy; UK pathways for Achilles tendinopathy centre on a structured loading/exercise programme. Camden's own reading of the primary literature beneath that guidance: The Praet 2019 RCT (Nutrients, N=20 active arms) randomised chronic Achilles tendinopathy patients to a structured calf-strengthening programme with either hydrolysed collagen peptides (TENDOFORTE) or placebo. The collagen arm gained 12.6 VISA-A points at three months versus 5.3 points for placebo. Single small trial; the structured exercise programme is the primary intervention; collagen as an adjunct is an early signal, not an established treatment. [10]
Bone mineral density in postmenopausal women
LimitedEvidencelimitedUK/EU authoritative guidance first: the Royal Osteoporosis Society has reviewed the publicly available collagen-and-bone evidence and judged it unclear, citing small studies with conflicting results, and advises that collagen should not replace established osteoporosis treatment; NICE CG146 does not list collagen peptides among recommended interventions. Camden's own reading of the primary trial literature beneath that guidance: The Konig 2018 RCT (Nutrients, N=131 postmenopausal women, 12 months) gave 5 g/day specific collagen peptides (FORTIBONE) or placebo. The collagen arm showed significantly increased BMD at the spine and femoral neck and a more favourable bone-marker profile. Single-product, single-sponsor trial. NICE CG146 (osteoporosis: assessing the risk of fragility fracture) does not list collagen peptides among recommended pharmacological or nutritional interventions; the established UK pathway is calcium and vitamin D adequacy plus bisphosphonates or denosumab where indicated. Collagen peptides are not a substitute for that pathway. [9,3]
Safety
Collagen peptides are generally well tolerated and the safety database from clinical trials is reassuring at typical doses (up to 10 g/day for several months). The main practical safety questions are about allergens (fish, shellfish for marine sources), kidney disease (high-protein loads of any kind), and absorption interactions with levothyroxine (separate by 4 hours).
Talk to your pharmacist or GP first if you:
- You take levothyroxine — protein-rich foods and supplements can reduce levothyroxine absorption; separate any collagen dose from your levothyroxine by at least 4 hours, as you would with any other protein supplement.
- You have chronic kidney disease or are on dialysis — high-protein supplementation needs to be discussed with your renal team.
- You have a fish or shellfish allergy and the product contains marine collagen — check the species declaration on the label.
- You follow a halal or kosher diet — bovine collagen is only halal / kosher with appropriate slaughter and a recognised certification on the label; porcine collagen is neither.
- You are pregnant or breastfeeding — there is no specific safety concern with hydrolysed collagen at typical doses, but pregnancy is a context in which any supplement deserves a midwife or GP conversation.
- Your joint pain is new, severe, or persistent — there are diagnosable causes (osteoarthritis, inflammatory arthritis, gout, injury) that no supplement will fix; see your GP.
Common side effects: Mild gastrointestinal complaints (bloating, fullness, occasional loose stool) are the most commonly reported. Serious adverse events in published trials are rare.
Pregnancy and breastfeeding
Hydrolysed collagen has no specific recognised safety concern in pregnancy at typical food-supplement doses, and the amino acids it provides are abundant in normal diet. There are no pregnancy-specific RCTs and routine megadose supplementation in pregnancy is not recommended. Marine collagen carries a fish- allergen consideration. UK NHS guidance is to obtain protein from a varied diet during pregnancy. Speak to your midwife, GP, or pharmacist before starting any new supplement in pregnancy.
No specific concern at typical doses; standard protein-and-amino-acid metabolism applies. Discuss with a midwife, GP, or pharmacist if uncertain.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Known allergy to the species source (fish allergy and marine collagen; bovine or porcine allergy where established).
- Phenylketonuria (PKU) — collagen contains phenylalanine; specialist dietary advice applies.
Drug interactions
- Levothyroxine — protein loads, including hydrolysed collagen at 5-10 g/day, can reduce levothyroxine absorption when taken concurrently. Separate the doses by at least 4 hours, as is standard for any high-protein supplement.
- No well-established direct pharmacokinetic interactions with anticoagulants, antihypertensives, or antidiabetics. Collagen is digested as a protein and metabolised through standard amino-acid pathways.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild gastrointestinal complaints (bloating, fullness, occasional loose stool) at higher daily doses.
- Aftertaste — particularly with marine collagen; flavoured drinks and gummies mask this with sugar or sweeteners.
Rare side effects
- Hypersensitivity reactions — uncommon, but reported particularly with marine collagen in people with fish allergy.
- Hypercalcaemia has been reported with very high doses of shark-cartilage preparations; not a concern with standard hydrolysed bovine or marine collagen.
How to take it
- Typical supplemental range
- Hydrolysed collagen peptides 2.5-10 g/day for 8-12+ weeks for skin endpoints; 10 g/day for joint endpoints; undenatured Type II collagen (UC-II) 10-40 mg/day for joint endpoints (a different preparation entirely). Collagen is not an essential nutrient — the body synthesises it from amino acids — so there is no UK reference intake.
- Timing
- No clear evidence that timing matters. Take consistently.
How to spot quality
Look for
- Species and tissue declared on the label: bovine hide / marine fish skin / porcine / chicken cartilage — not just "collagen".
- Hydrolysed collagen peptides specifically (not intact collagen, which is not absorbed as collagen) with molecular weight stated, typically 2-5 kDa.
- GMP-certified manufacture; ideally third-party testing for heavy metals — particularly important for marine collagen because fish skin can concentrate heavy metals from environmental exposure.
- Allergen declaration matches the species: fish gelatin and marine collagen are declared fish allergens under the UK Food Information Regulations 2014; bovine collagen carries BSE-traceability requirements (sourced from a TSE-controlled supply chain).
- Vitamin C present at the GB NHC threshold (12 mg per portion, 15% NRV) if the label carries any collagen-formation phrasing — that phrasing is a vitamin C claim, not a collagen claim, and the threshold has to be met.
Red flags
- Anti-wrinkle, youth-restoring, or reverse-skin-ageing marketing copy — none of these are authorised claims under GB NHC and they are CAP §15 violations.
- "Vegan collagen" or "plant collagen" wording — collagen is an animal protein and these products are amino-acid stacks marketed deceptively.
- Unspecified "collagen complex" without species, tissue, or molecular weight.
- Skin / hair / nail / joint claims printed as collagen claims rather than as the vitamin C / biotin / selenium claim they legally are.
- Hyaluronic acid + collagen stacks marketed under skin-rejuvenation positioning — neither has a UK-authorised health claim for skin appearance.
- Collagen drinks marketed for "gut healing" or "leaky gut" — there is no UK-authorised claim and no robust evidence base for this positioning.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Vitamin C
Moderate evidenceVitamin C is the required cofactor for the enzymes that build the collagen triple helix.
Collagen synthesis in fibroblasts depends on prolyl-hydroxylase and lysyl-hydroxylase enzymes, which use vitamin C (ascorbic acid) as an obligate cofactor to hydroxylate proline and lysine residues in nascent procollagen chains. Hydroxyproline and hydroxylysine are required for triple-helix stability and cross-linking. Without vitamin C, collagen synthesis fails (the underlying lesion in scurvy). Co-supplementation is studied for skin elasticity, tendon repair (DePhillipo 2018), and post-surgical wound healing. Vitamin C-enriched gelatin/collagen taken 30–60 minutes before short bouts of exercise increased collagen synthesis markers in young athletes (Shaw 2017).
Evidence: Pullar 2017 (Nutrients) reviews vitamin C in skin biology. DePhillipo 2018 (Orthop J Sports Med) systematic review on vitamin-C-enriched gelatin for tendon repair. Shaw 2017 (Am J Clin Nutr) demonstrated the pre-exercise collagen+VitC protocol. Mechanistic case is strong; clinical-outcome trials remain modest in size. [11,12,13,14]
Doses studied: 500 mg vitamin C with 5–15 g hydrolysed collagen, taken 30–60 min before exercise (DePhillipo 2018 / Shaw 2017 protocol)
Biotin
Limited evidenceBeauty-cluster pairing — biotin + collagen support hair / skin / nails framework.
Biotin cofactor for keratinocyte fatty-acid synthesis; collagen peptide amino-acid substrate for dermal matrix. Complementary on beauty axis. UK Article 13.1 biotin hair / skin / mucous-membrane maintenance claims.
Evidence: UK Article 13.1 biotin claims authorised. [1]
Doses studied: 50-200 µg biotin (within UK NRV 50 µg) + 5-10 g/day hydrolysed collagen.
Calcium (Ca)
Limited evidenceBone matrix is ~70% mineral and ~30% organic — mostly type I collagen. Calcium provides the mineral; collagen provides the scaffold the mineral is laid into.
Bone is a composite material: the inorganic phase is calcium hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) accounting for roughly 70% of bone mass, and the organic phase is mostly type I collagen accounting for roughly 30%. Mineralisation occurs onto the collagen scaffold during bone formation; mineral can be drawn from the matrix during resorption.
Hydrolysed collagen peptide supplementation (typically 5-10 g/day) has been studied for postmenopausal bone-mineral density (König 2018 Nutrients; Argyrou 2020 J Musculoskelet Neuronal Interact) with modest signals on BMD and bone-turnover markers. UK NICE bone-health pathway does not include collagen; the regulatory tier is food supplement with no UK-authorised bone claim for collagen.
The combination is mechanistically coherent — providing both the mineral and the organic-scaffold substrate — but the trial evidence is concentrated on each component separately. Camden's collagen entry carries the collagen-specific detail.
Evidence: König 2018 and Argyrou 2020 RCTs on hydrolysed collagen peptide and postmenopausal BMD are the most-cited combination-relevant trials. UK NICE pathway does not list collagen.
Doses studied: 500-1000 mg/day calcium with 5-10 g/day hydrolysed collagen peptide.
Polypeptides (Cosmetic peptides — signal / carrier / neurotransmitter-inhibiting)
Limited evidenceTop-down (oral collagen) + bottom-up (topical peptide) skin-matrix support framing.
Oral hydrolysed collagen peptide provides systemic amino-acid substrates for dermal collagen synthesis; topical cosmetic peptides provide direct fibroblast signalling at the application site. Different mechanisms; complementary marketing framing.
Evidence: Each component has individual trial body; combination not directly trialled.
Doses studied: Topical peptide serum + oral hydrolysed collagen peptide 5-10 g/day.
Retinaldehyde (Retinal)
Limited evidenceSame downstream-stimulation framing as retinol.
Topical retinaldehyde converts to retinoic acid → procollagen up-regulation. Oral collagen peptide provides amino-acid substrates.
Evidence: Mechanism per retinol pairing.
Doses studied: Retinaldehyde 0.05-0.1% topical PM + oral hydrolysed collagen 5-10 g/day.
Retinol (Vitamin A1, all-trans-retinol)
Limited evidenceThe collagen-stimulation axis — topical retinol is one of the few topical actives with documented trial evidence for increased dermal procollagen expression. Pairs with oral hydrolysed collagen peptide for top-down + bottom-up framing.
Topical retinoic acid (the active form retinol converts to in skin) up-regulates type-I and type-III procollagen gene expression in dermal fibroblasts and down-regulates MMP-1 (the principal collagenase). The net effect over 6-12 months of consistent use is increased dermal collagen content and reduced collagen breakdown — the documented anti-photoaging mechanism (Mukherjee 2006, Kang 2003).
Oral hydrolysed collagen peptide (typically 5-10 g/day; König 2018, Argyrou 2020 trials) provides amino-acid substrates plus signalling peptides (proline-hydroxyproline, hydroxyproline) that have modest signals on dermal collagen markers. The mechanism is upstream nutritional support; topical retinol is the direct dermal-level remodelling driver.
The "top-down + bottom-up" framing is real but not synergistic in any well-trialled sense — each component has its own modest trial body, neither has a UK-authorised health claim for skin or photoaging endpoints. UK NICE pathway for cosmetic photoaging concerns is education on sun protection + topical retinoid (private dermatology routes). Camden's collagen covers the oral side.
Evidence: Topical retinol → dermal procollagen up-regulation is well- established (Mukherjee 2006; Kang 2003). Oral hydrolysed collagen → dermal collagen markers is modest trial evidence (König 2018; Argyrou 2020). Combination not directly trialled.
Doses studied: Retinol 0.2-0.5% topical evening + hydrolysed collagen peptide 5-10 g/day oral.
Vitamin C topical (L-ascorbic acid + ester derivatives)
Limited evidenceProcollagen-cofactor mechanism — ascorbic acid is the cofactor for prolyl / lysyl hydroxylase enzymes that hydroxylate procollagen. Topical vitamin C + oral collagen peptide is mechanism-coherent for collagen-supportive framing.
Ascorbic acid is required for the post-translational hydroxylation of proline and lysine residues in procollagen polypeptide chains; without adequate ascorbate, the resulting collagen is unstable. The systemic mechanism of scurvy (impaired wound healing, easy bruising, dental concerns) demonstrates the load-bearing nature of ascorbate in collagen biology.
Topical vitamin C at high local concentrations may locally support fibroblast collagen synthesis — the basis for the photoaging-trial signal. Oral hydrolysed collagen peptide provides amino-acid substrates plus signalling peptides. The two address different parts of the collagen biology.
UK Article 13.1 authorised vitamin C claim "Vitamin C contributes to normal collagen formation for the normal function of skin" supports the regulatory framing for the systemic side; topical claims operate under EU Cosmetic Regulation.
Evidence: Mechanism well-established (procollagen hydroxylation cofactor). UK Article 13.1 collagen-formation claim authorised. Combination trials small. [1]
Doses studied: Topical 15% LAA AM + oral hydrolysed collagen peptide 5-10 g/day + UK Article 13.1-cited oral vitamin C ≥80 mg/day.